Projects funded by the NCN
Photoimmunotherapy - novel therapeutic strategy for glioblastoma.
2017/25/B/NZ5/00039
Keywords:
glioblastoma EGFR affibody photoimmunotherapy
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_5: Diagnostics in human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Zaawansowanych Technologii
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 1 647 680 PLN
Project start date (Y-m-d): 2018-01-12
Project end date (Y-m-d): 2022-11-11
Project duration:: 58 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.Authors:Justyna Mączyńska, Florian Raes, Chiara Da Pieve, Stephen Turnock, Jessica K R Boult, Julia Hoebart, Marcin Niedbala, Simon P Robinson, Kevin J Harrington, Wojciech Kaspera, Gabriela Kramer-MarekAcademic press:BMC Medicine (rok: 2022, tom: 20, strony: 45674), Wydawca: SpringerStatus:PublishedDOI:10.1186/s12916-022-02388-z - link to the publication